Systematic review and evidence- based guidance ... - ECDC - Europa
Systematic review and evidence- based guidance ... - ECDC - Europa
Systematic review and evidence- based guidance ... - ECDC - Europa
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Systematic</strong> <strong>review</strong> <strong>and</strong> <strong>evidence</strong>-<strong>based</strong> <strong>guidance</strong> on perioperative antibiotic prophylaxisTECHNICAL REPORTPAP modality Author <strong>and</strong> design of study Quality of<strong>evidence</strong>according tothe GRADEapproach*[24,25]Expertgrading onstrength of<strong>evidence</strong>;median(range)Expert grading ofimplementability;median (range)7 Although a single doseof PAP is preferred,subsequent dosesshould be givendepending on theduration of theprocedure <strong>and</strong> the halflifeof the antibiotic,<strong>and</strong> if significant bloodloss occurs duringsurgery.8 Prolonging prophylaxisafter the end of surgeryis not recommended.9 The PAP protocolshould take intoaccount individualpatient factors like BMI,underlying diseases, orcolonisation withresistant pathogens.Zani 2011, systematic <strong>review</strong>McDonald 1998, systematic <strong>review</strong>Gillespie 2010, Cochrane systematic <strong>review</strong>Meijer 1990, systematic <strong>review</strong>Nelson 2009, Cochrane systematic <strong>review</strong>Slobogean 2008, systematic <strong>review</strong>Southwell-Keely 2004, systematic <strong>review</strong>Zannetti 2003, RCTZani 2011, Cochrane systematic <strong>review</strong>Gillespie 2010, Cochrane systematic <strong>review</strong>Nelson et al. 2009, Cochrane systematic <strong>review</strong>Southwell-Keely 2004, systematic <strong>review</strong>Dhadwal 2007, double blind RCTNúnez-Pererira 2011, non-CBAGarey 2008, ITS studyKato 2007, non-CBAWagner 2011, non-CBALinam 2010, case-control studySchelenz 2005, non-CBASharma 2009, non-CBA10 In surgicalItani et al. 2008, RCTdepartments, patterns Carignan 2008, retrospective cohort studyof MDROs <strong>and</strong> Kato et al. 2007, non-CBAincidence of Clostridiumdifficile infectionsshould be monitoredproactively so PAP canbe appropriatelyadjusted.43333333433343222211432(1=stronglydisagree to6=strongly agree)6 (4-6) 6 (4-6)6 (2-6) 6 (2-6)5 (2-6) 6 (5-6)4 (3-6) 5 (2-6)(1=strongly discouragedto 6=implementationstrongly recommend )* Quality of <strong>evidence</strong> according to the GRADE approach [24,25]: 4=high quality, 3=moderate quality, 2=low quality, 1=very lowqualityDefining EU-wide applicability/implementability <strong>and</strong> addressing barriersIn order to facilitate the discussion <strong>and</strong> the ranking it was necessary to define terms such as ‘EU-wide applicability’<strong>and</strong> ‘EU-wide implementability’. The experts were asked to identify key components of these terms so that theycould be easily understood <strong>and</strong> their ranking <strong>and</strong> consensus transparent <strong>and</strong> homogeneous. Components such asfinancial resources, educational aspects, staff resources, cultural issues <strong>and</strong> hierarchical aspects were some of theidentified topics. While discussing these components, the expert also identified several barriers to EU-wideapplicability <strong>and</strong> implementability. It was decided to draw a list of potential barriers for each PAP modality, <strong>based</strong>on a short literature <strong>review</strong> <strong>and</strong> expert input. These barriers were expected to be different in each country,depending on socio-economic <strong>and</strong> political factors, but the identification of such barriers could be used to fine-tunethe implementation details for the PAP modalities.Final five key modalitiesDuring this second expert meeting, each modality was discussed separately <strong>and</strong> either rejected, included, orcombined with another modality. The final five key PAP modalities are listed in Table 21.30